FDA Approves Regeneron’s Livsayis for AChR-Positive Generalized Myasthenia Gravis
The FDA approved Livsayis (cemdisiran) for adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.
The FDA approved Livsayis (cemdisiran) for adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.